Rutika Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 24-05-2024
- Paid Up Capital ₹ 0.10 M
as on 24-05-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 245883.00%
(FY 2019)
- Profit 102.62%
(FY 2019)
- Ebitda 116.23%
(FY 2019)
- Net Worth 91.62%
(FY 2019)
- Total Assets 198.94%
(FY 2019)
About Rutika Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Meghana Dhamnaskar, Amit Dhamnaskar, and Kavita Dhamnaskar serve as directors at the Company.
- CIN/LLPIN
U24299MH2017PTC302343
- Company No.
302343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rutika Lifescience Private Limited offer?
Rutika Lifescience Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Common Disease Medicines, Antihistamines, Antifungal Injection, Tablet & Syrup, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Rutika Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meghana Dhamnaskar  | Additional Director | 21-Aug-2020 | Current |
| Amit Dhamnaskar | Additional Director | 21-Aug-2020 | Current |
| Kavita Dhamnaskar | Director | 01-Dec-2017 | Current |
Financial Performance and Corporate Structure Insights of Rutika Lifescience.
Rutika Lifescience Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 245883% increase. The company also saw a substantial improvement in profitability, with a 102.62% increase in profit. The company's net worth Soared by an impressive increase of 91.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rutika Lifescience?
Unlock access to Rutika Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rutika Lifescience?
Unlock and access historical data on people associated with Rutika Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rutika Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rutika Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
